Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
06/2008
06/18/2008CN101203509A Amine-linked pyridyl and phenyl substituted piperazine-piperidines with CXCR3 antagonist activity
06/18/2008CN101203508A Substituted pyrr0lidin-2-0nes , piperidin-2-0nes and isothiazolidine-1, 1-dioxides, their use as kvl .5 potassium channel blockers and pharmaceutical preparations comprising them
06/18/2008CN101203507A 2-substituted benzimidazoles
06/18/2008CN101203506A Heterocyclylaminoalkyl substituted benzimidazoles
06/18/2008CN101203505A Chromane and chromene derivatives and uses thereof
06/18/2008CN101203495A Benzocycloheptapyridines as inhibitors of the receptor tyrosine kinase met
06/18/2008CN101203494A Methods of synthesizing substituted 3-cyanoquinolines and intermediates thereof
06/18/2008CN101203491A Tetrahydrocarbazole derivatives used as androgen receptor modifier
06/18/2008CN101203489A Oxindole derivatives
06/18/2008CN101203134A Substituted arylpyrazoles as parasiticidal pharmaceutical product
06/18/2008CN101200450A 2,6-quinolinyl and 2,6-naphthyl derivatives, processes for preparing them and their uses as vla-4 inhibitors
06/18/2008CN100395244C Quinolone carboxylic acid derivatives or their salts
06/18/2008CN100395237C 2,5-substituted tetrahydroisoquinolines for use as 5-HT6 modulators
06/18/2008CN100395234C Novel CB1 receptour inverse agonists
06/17/2008US7388095 modulation of H3 Histamine receptors; e.g. 5-(4-isopropyl-morpholin-2-ylmethoxy)-1-(2,2,2-trifluoro-ethyl)-1H-indol-2-yl]-morpholin -4-yl-methanone; antagonists/inverse agonists
06/17/2008US7388026 Antitumor antibiotic; water solubility, stability; N-[2-{(1-chloromethyl)-1,2-dihydro-5-[(4-methylpiperazino)carbonyloxy]-3H-benz(e)indol-3-yl}carbonyl]-1H-indol-5-yl]-5-[(3-methyldithio-1-oxopropyl)-amino]-1H-indole-2-carboxamide
06/17/2008US7388021 Novel pyridyl or phenyl ureas and analogues; Purinoreceptors inhibitors; 1-(4-tert-butylphenyl)-3-(2-(3-isopropylphenoxy)pyridin-3-yl)urea; for the treatment of a thromboembolic disorders
06/17/2008US7388020 Compounds for chronic obstructive pulminary disorders for breathingand respiratory system diorders
06/17/2008US7388018 for controlling phytopathogenic harmful fungi;
06/17/2008US7388014 Quinazoline derivatives and therapeutic use thereof
06/17/2008CA2501799C Pyrazole compounds for treatment of neurodegenerative disorders
06/17/2008CA2439152C Acylated piperidine derivatives as melanocortin-4 receptor agonists
06/17/2008CA2395193C Pyrrolidine derivatives as cyclic amp-specific phosphodiesterase inhibitors
06/17/2008CA2393749C Substituted 8-arylquinoline phosphodiesterase-4 inhibitors
06/17/2008CA2330798C Febrifugine, isofebrifugine and method for producing the same
06/17/2008CA2289409C Sulfoxide compounds and acetone complexes, and a process for producing the same
06/17/2008CA2286772C Fungicide active substance combinations
06/17/2008CA2272291C Crf antagonistic quino- and quinazolines
06/17/2008CA2261762C Substituted 2(2,6-dioxopiperidin-3-yl)phthalimides and -1-oxoisoindolines and method of reducing tnf-alpha levels
06/12/2008WO2008070661A1 Substituted pyrimidines as adenosine receptor antagonists
06/12/2008WO2008070583A2 Thrombopoietin mimetics
06/12/2008WO2008070507A2 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/12/2008WO2008070447A2 Anti-viral compounds
06/12/2008WO2008070350A2 Methods and compositions related to wrapping of dehydrons
06/12/2008WO2008070305A2 1, 5-diphenyl-3-pyridinylamino-1, 5-dihydropyrrolidin-2-one as cbl' receptor modulator
06/12/2008WO2008069997A1 Substituted diazepan compounds as orexin receptor antagonists
06/12/2008WO2008069313A1 Method for producing pyrrolidine compound
06/12/2008WO2008069242A1 Novel bicyclic heterocyclic compound
06/12/2008WO2008068767A2 A novel crystalline form of lansoprazole
06/12/2008WO2008068614A2 Stereoselective synthesis of 1-[6-ethyl-1,2-dihydroxy-propyl)-pyridin-3-yl]-3-[2-(4-methyl-piperazin-1-yl)-benzyl]-pyrrolidin-2-one
06/12/2008WO2008068507A2 2 -phenylamino, 6- (pyrid-3-yl) quinazoline derivatives as raf-protein kinase inhibitors in cancer treatment
06/12/2008WO2008068470A1 Antibacterial polycyclic urea compounds
06/12/2008WO2008068423A2 P<0}{0pyrrol derivatives, preparation and use of the same in therapy<0}
06/12/2008WO2008068277A1 Piperidinylamino-pyridazines and their use as fast dissociating dopamine 2 receptor antagonists
06/12/2008WO2008068272A2 Antibacterial quinoline derivatives
06/12/2008WO2008068270A1 Antibacterial quinoline derivatives
06/12/2008WO2008068268A1 Antibacterial quinoline derivatives
06/12/2008WO2008068267A1 Antibacterial quinoline derivatives
06/12/2008WO2008068266A1 Antibacterial quinoline derivatives
06/12/2008WO2008068184A1 Indoles which act as via receptor antagonists
06/12/2008WO2008068183A1 Indoles
06/12/2008WO2008068157A1 2-aminoquinolines as 5-ht(5a) receptor antagonists
06/12/2008WO2008067874A1 Substituted dipyridyl-dihydropyrazolones and use thereof
06/12/2008WO2008067871A1 Substituted dihydropyrazolones for treating cardiovascular and haematological diseases
06/12/2008WO2008067710A1 Substituted cyclohexane compounds, preparation methods and medicine uses thereof
06/12/2008WO2008067709A1 Substituted cyclobutane compounds, preparation methods and pharmaceutical uses thereof
06/12/2008WO2008057300A3 Trpvi antagonists and uses thereof
06/12/2008WO2008047210A3 Compounds derived from 1 -ethyl-4,5-diamino-pyrazole and their use for oxidative dyeing of keratin fibres
06/12/2008WO2008045777A3 A process for the preparation of benzimidazole derivatives and their salts
06/12/2008WO2008031556A3 2 amino-pyrimidine derivatives as h4 receptor antagonists, processes for preparing them and their use in pharmaceutical compositions
06/12/2008WO2008015517A3 Ep2 agonists
06/12/2008WO2007110237A3 Amide derivatives and their application for the treatment of g protein related diseases
06/12/2008US20080139811 Reacting an amino, hydroxy substituted amide with a heterocyclic substituted carboxylic acid to produce (2S,3S,5S)-2-(2,6-Dimethylphenoxyacetyl) amino-3-hydroxy-5-[2S-1-imidazolidin-2-onyl)-3-methyl-butanoyl] amino-1,6-diphenylhexane; inhibitors of HIV infection
06/12/2008US20080139788 Acridone derivatives as labels for fluorescence detection of target materials
06/12/2008US20080139627 Heterocyclic amide and imine derivatives, processes for their preparation, compositions comprising them and their use as pesticides
06/12/2008US20080139623 Amorphous and crystalline forms of pantoprazole magnesium salt
06/12/2008US20080139621 Thrombocytopenia; administering a thrombopoietin receptor agonist; 4-(2-hydroxyphenyl)piperidin-1-yl-acetic acid; 3-(2-hydroxyphenyl)cyclohexane-carboxylic acid; 3-(3'-{2-[1-(3,4-dimethylphenyl)-3-methyl-5-oxo-4,5-dihydro-1H-pyrazol-4-ylidene]hydrazino}-2'-hydroxy-phenyl)cyclohexane-1-carboxylic acid
06/12/2008US20080139620 Pyrazole Derivatives For The Inhibition Of Cdk's And Gsk's
06/12/2008US20080139619 Novel derivatives of benzimidazale and imidazo-pyridine and their use as medicaments
06/12/2008US20080139618 Indoles
06/12/2008US20080139613 4-{(1R,3R)-1-(3,5-difluorophenyl)-3-[4-(3-ethyl-5-isopropyl-4H-1,2,4-triazol-4-yl)piperidin-1-yl]butyl}-1-(methylsulfonyl)piperidine; for treatment of CCR5 disease states
06/12/2008US20080139612 Chemical Compound
06/12/2008US20080139594 e.g. 4-[8-Chloro-2-(3-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl]-n-phenylpyrimidin-2-amine; synthesis
06/12/2008US20080139579 Hiv Integrase Inhibitors
06/12/2008US20080139575 Certain chemical entities, compositions, and methods
06/12/2008US20080139574 Novel quinoline derivatives
06/12/2008US20080139572 Diketo-piperazine and piperidine derivatives as antiviral agents
06/12/2008US20080139561 e.g. 6-(5-Cyclopropyl-1H-pyrazol-3-ylamino)-5-fluoro-2-(1-(4-fluorophenyl)ethylamino) nicotinonitrile; tropomyosin-related kinases (Trk's) inhibitor; anticarcinogenic agent; hormone related cancer, leukemia; antiinflammatory agent; arthritis, restenosis; autoimmune diseases
06/12/2008US20080139560 Ion Channel Modulators
06/12/2008US20080139557 [5-(Pyridin-2-ylamino)-6-oxo-1,6-dihydro-pyridin-3-yl]-(3-amido)-benzene derivatives; anticarcinogenic, antiproliferative, antiallergen, and antiinflammatory agents; lymphoma, leukemia, autoimmune diseases; Bruton's tyrosine kinase inhibitors
06/12/2008US20080139555 1-[(4-{[4-(3-amino-6-methylphenyl)piperidyl]methyl}phenyl)sulfonyl]-4; melatonin-concentrating hormone (MCH1) receptor ligand; antidepressant, anxiolytic, antidiabetic agent
06/12/2008US20080139554 Spiro-piperidine derivatives
06/12/2008US20080139553 Spiro-piperidine derivatives
06/12/2008US20080139552 Indoles
06/12/2008US20080139550 e.g. {5-Chloro-2-[4-(2-oxo-2,3-dihydro-benzooxazol-7-yl)-piperidine-1-carbonyl]-1H-indol-7-yl}-acetonitrile; vasopressin receptors antagonist; antidepressant, anxiolytic agent; dysmenorrhea, hypertension, inappropriate secretion of vasopressin, liver cirrhosis, obsessive compulsive disorder
06/12/2008US20080139549 Indoles
06/12/2008US20080139548 Indoles
06/12/2008US20080139547 N-Hydroxyalkynylbenzamide (or hydroxamate) derivatives; anticarcinogenic and antiproliferative agents
06/12/2008US20080139544 Modulators of CCR5(chemokine) receptors; lymphadenopathy associated and human T-cell leukemia/lymphoma viruses; AIDS infections; autoimmune diseases; antiinflammatory agents; derivatives of 1-oxa-3,8-diaza-spiro[4.5]decan-2-one and 1-oxa-3,9-diaza-spiro[5.5]undecan-2-one
06/12/2008US20080139538 Tertiary Carbinamines Having Substituted Heterocycles Which Are Active As Beta-Secretase Inhibitors For The Treatment Of Alzheimer's Disease
06/12/2008US20080139536 Benzodiazepines for Treating or Preventing Rsv Infection
06/12/2008US20080139535 1-(2-naphthylsulfonyl)-4-(5-hydroxyaminocarbonylthiazol-2-yl)piperazine; antiproliferative agent; cell cycle arrest, cellular differentiation, apoptosis and reversal of the transformed phenotype;
06/12/2008US20080139533 Substituted 4-imidazoles
06/12/2008US20080139532 Tetrahydrobenzazepine Derivatives as Modulators of Dopamine D3 Receptors (Antipsychotic Agents)
06/12/2008US20080139505 Potentiators Of Glutamate Receptors
06/12/2008US20080135803 Pyridyl derivatives with substituents of electrons push-pull effect; compounds are colorless and have high thermal and photo stability as well as high compatibility in liquid crystal host; can reduce threshold voltage of cholesteric reflective displays, saving power and extending lifetime of driver ICs
06/12/2008DE102006053644A1 Neuartiges hochleitfähiges organisches Ladungsträgertransportmaterial Novel highly conductive organic charge transport material
06/12/2008CA2671990A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
06/12/2008CA2671749A1 Bicyclic compounds and uses as antidiabetics
06/12/2008CA2671324A1 Indoles which act as via receptor antagonists
1 ... 378 379 380 381 382 383 384 385 386 387 388 389 390 391 392 393 394 395 396 397 398 ... 1080